GlassScriptPhysician profile
Daniel S Bond
NPI 1770111502
$1,237.59
in general payments reported to CMS, 2019-2025
15 companies · $891 in 2025
The $891 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.17 · 2024: $335 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $614.70 | 2024-2025 | Acessa Provu System, Fluent Fluid Management System, Novasure |
| Astellas Pharma US INC | $160.35 | 2025 | Veozah |
| Intuitive Surgical, INC. | $103.90 | 2024 | |
| Sumitomo Pharma America, INC. | $52.68 | 2024-2025 | Myfembree, Gemtesa |
| Millicent US INC | $51.85 | 2025 | Femlyv |
| Mayne Pharma Commercial LLC | $49.61 | 2025 | |
| Boston Scientific Corporation | $47.95 | 2024 | Capio Rp |
| Exeltis, USA INC. | $32.17 | 2024-2025 | Slynd |
| Exact Sciences Corporation | $31.61 | 2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $23.95 | 2025 | Vistaseal, Evarrest, Stratafix |
| Baxter Healthcare | $19.22 | 2024 | Renal - Pd |
| Lilly USA, LLC | $14.48 | 2025 | Zepbound |
| Dexcom, INC. | $14.45 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $12.17 | 2022 | |
| Organon LLC | $8.50 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.